Skip to content

Evaluate Aerobic Exercise on Myocardial Fibrosis and Intestinal Flora in Dilated Cardiomyopathy Diagnosed First Time.

Study on the Changes of Intestinal Flora and Cardiac Fibrosis in Patients With Dilated Cardiomyopathy Diagnosed for the First Time by Sports Rehabilitation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06039969
Enrollment
30
Registered
2023-09-15
Start date
2023-10-01
Completion date
2025-10-01
Last updated
2023-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Rehabilitation, Myocardial Fibrosis

Keywords

Aerobic exercise rehabilitation, Myocardial Fibrosis, human gut microbiome, cardiac magnetic resonance

Brief summary

To invegstive the Changes of Intestinal Flora and the improvements of Cardiac Fibrosis in Patients With Dilated Cardiomyopathy Diagnosed for the First Time by heart Rehabilitation

Detailed description

Previous studies have confirmed that Aerobic exercise rehabilitation can reduce the rate of readmission of patients with heart failure and improve their cardiopulmonary endurance and exercise ability. However, whether aerobic exercise rehabilitation can inhibit myocardial fibrosis or delay the progress of fibrosis in patients with heart failure has not been reported. At the same time, some studies have shown that the change of intestinal microbial flora may promote the progress of heart failure, and regular aerobic exercise will also lead to the change of intestinal microbial flora, but whether aerobic exercise rehabilitation can improve intestinal microbial flora in patients with dilated cardiomyopathy has not been reported. In our study, patients who were hospitalized for heart failure for the first time and were finally diagnosed with dilated cardiomyopathy were recruited. Recruited patients will enter the routine cardiac rehabilitation process and make an individualized aerobic exercise plan according to the cardiopulmonary exercise test. Cardiac MRI and intestinal microflora changes will be evaluated.

Interventions

None listed

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 1、Patients hospitalized for the first time because of heart failure 2、The patient who was definitely diagnosed as dilated cardiomyopathy for the first time

Exclusion criteria

* 1、Other types of cardiomyopathy 2、Has been diagnosed as dilated cardiomyopathy. 3、malignant tumor 4、acute infection 5、Cannot perform cardiopulmonary exercise test.

Design outcomes

Primary

MeasureTime frameDescription
myocardial fibrosisfirst admission six months one yearAssessment of myocardial fibrosis based on cardiac MRI examination

Secondary

MeasureTime frameDescription
Bacterial spectrum of intestinefirst admission six months one yearAssessment of Bacterial spectrum of intestine based on Patient feces sequencing

Other

MeasureTime frameDescription
cardiac fitinessfirst admission six months one yearAssessment of caridac fitness based on ardiopulmonary exercise test

Countries

China

Contacts

Primary ContactJin Geng, MD
gj885258@163.com+86-17753124846
Backup ContactXiWen Zhang, MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026